← Back to Clinical Trials
Recruiting NCT06754475

Effects of Upper Extremity Low Volume HIIT in Heart Failure

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition High Intensity Interval Training
Sponsor Tarsus University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 30
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-11-01
Completion 2026-11-01
Interventions
Low-volume, high-intensity interval trainingStandart medical treatment

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study was planned to investigate the effects of upper extremity low-volume high-intensity interval training (LV-HIIT) on physical and cognitive function in patients with heart failure with preserved ejection fraction(HFpEF).The research was planned as a randomized controlled trial. Patients with clinically stable HFpEF at cardiology clinic will be included in the study. These cases will be randomly divided into two groups: intervention group and control grup. After 8 weeks intervention physical functions before and after treatment; functional exercise capacity, arm exercise capacities , peripheral muscle strength , fatigue cognitive functions; anxiety and depression and fear of movement will be evaluated.

Eligibility Criteria

Inclusion Criteria: * Clinical condition stable for ≥4 weeks. * New York Heart Association functional classification I-II to III * Over 18 years old Exclusion Criteria: History of CABG surgery * Unstable angina pectoris * Severe arrhythmia * Acute pericarditis, endocarditis, myocarditis * Severe left ventricular failure (EF \<40%) * Acute pulmonary embolism * History of syncope * Dissecting aneurysm * Thrombophlebitis * Orthopedic disorders that may interfere with exercise * Uncontrolled hypertension, severe pulmonary arterial hypertension * Moderate-severe valve disease * Decompensated Congestive Heart Failure * Electrolyte abnormalities * Hypertrophic Cardiomyopathy

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}